Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mildronate efficacy and safety in stable angina (II)
2004-001611-58Phase 3Completed
- Sponsor
- Grindeks
- Start
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of meldonium in coronary arteriosclerosis and stable angina, sponsored by Grindeks. Primary endpoint: Change in exercise time in bicycle ergometry. Started Dec 2004; status: completed.
02
Drugs
meldonium
03
Conditions
coronary arteriosclerosisstable angina
Beyond the preview
Go deeper on 2004-001611-58.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001611-58.